NewsBenzinga恒瑞医药与Braveheart Bio公布HRS/BHB-1893在梗阻性肥厚型心肌病(oHCM)中的持久52周获益;称在肥厚型心肌病(HCM)两种类型及临床前模型中的数据表明,该药有望针对疾病的潜在病理生理机制;研究结果与逆向重构及舒张功能获益一致;将于今日美国东部时间下午4:35举办投资者活动并进行网络直播 恒瑞医药与Braveheart Bio公布HRS/BHB-1893在梗阻性肥厚型心肌病(oHCM)中的持久52周获益;称在肥厚型心肌病(HCM)两种类型及临床前模型中的数据表明,该药有望针对疾病的潜在病理生理机制;研究结果与逆向重构及舒张功能获益一致;将于今日美国东部时间下午4:35举办投资者活动并进行网络直播 Benzinga 2026.11.06 20:17 (GMT+0) Open on Benzinga Other news Allied Gold Advances Exploration And Design Activities At Tsenge Trend To Expand Additional Mining Area; Affirms Plan For Base Dividend Starting In 2027 And Normal Course Issuer Bid For Up To 10% Of Public Float Global-E Online Stock Is Falling Wednesday: What's Going On? Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease HC Wainwright & Co. Maintains Buy on Cerenome, Raises Price Target to $7 Streamex Launches Yield Bearing Gold Asset GLDY As Available Asset To IRA Account Holders Of Equity Trust Company As Its First Tokenized Asset HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6
Allied Gold Advances Exploration And Design Activities At Tsenge Trend To Expand Additional Mining Area; Affirms Plan For Base Dividend Starting In 2027 And Normal Course Issuer Bid For Up To 10% Of Public Float
Grifols Presents New Real-World Evidence Data From AMBAR Program, Contributing To Ongoing Research Evaluating Use Of TPE With Albumin Replacement In Patients With Alzheimer’s Disease
Streamex Launches Yield Bearing Gold Asset GLDY As Available Asset To IRA Account Holders Of Equity Trust Company As Its First Tokenized Asset